Artal Group S.A. - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$128,133
-52.4%
117,553,2840.0%5.49%
-34.1%
Q2 2023$269,197
+23.4%
117,553,284
+30.9%
8.34%
-35.6%
Q1 2023$218,161
+27.2%
89,778,2340.0%12.96%
+35.4%
Q4 2022$171,476
-99.9%
89,778,2340.0%9.57%
+4.1%
Q3 2022$215,468,000
+62.8%
89,778,234
+26.1%
9.20%
+30.1%
Q2 2022$132,392,000
-11.0%
71,178,3640.0%7.07%
+13.5%
Q1 2022$148,763,000
-47.0%
71,178,3640.0%6.23%
-18.2%
Q4 2021$280,443,000
-18.1%
71,178,3640.0%7.61%
-0.7%
Q3 2021$342,368,000
+4.8%
71,178,3640.0%7.66%
+15.5%
Q2 2021$326,708,000
-21.8%
71,178,3640.0%6.63%
-10.2%
Q1 2021$417,817,000
+71.6%
71,178,3640.0%7.38%
+41.3%
Q4 2020$243,430,000
+180.6%
71,178,364
+18.2%
5.23%
+148.1%
Q3 2020$86,746,000
-27.8%
60,240,8640.0%2.11%
-37.4%
Q2 2020$120,181,000
+2.3%
60,240,8640.0%3.36%
-32.3%
Q1 2020$117,470,000
-53.0%
60,240,8640.0%4.96%
-48.6%
Q4 2019$249,999,000
+37.9%
60,240,8640.0%9.66%
+32.8%
Q3 2019$181,325,000
-52.1%
60,240,8640.0%7.27%
-52.6%
Q2 2019$378,915,000
+13.1%
60,240,8640.0%15.32%
+12.0%
Q1 2019$334,939,000
-16.3%
60,240,8640.0%13.68%
-7.7%
Q4 2018$400,000,000
-37.8%
60,240,8640.0%14.82%
-11.4%
Q3 2018$642,770,000
-11.1%
60,240,8640.0%16.72%
+8.8%
Q2 2018$722,891,000
+44.7%
60,240,864
+3.4%
15.36%
+145.8%
Q1 2018$499,413,000
-13.3%
58,274,6500.0%6.25%
-28.0%
Q4 2017$575,754,000
-18.6%
58,274,650
+1.3%
8.68%
-28.7%
Q3 2017$706,896,000
-25.3%
57,517,9770.0%12.18%
-26.3%
Q2 2017$946,170,000
+14.7%
57,517,9770.0%16.53%
-9.7%
Q1 2017$824,807,000
+3.7%
57,517,9770.0%18.31%
+3.7%
Q4 2016$795,474,000
-23.5%
57,517,9770.0%17.66%
-14.2%
Q3 2016$1,039,349,000
+25.9%
57,517,9770.0%20.58%
+20.8%
Q2 2016$825,383,000
+20.1%
57,517,9770.0%17.04%
+27.1%
Q1 2016$687,340,000
-10.2%
57,517,9770.0%13.41%
-6.7%
Q4 2015$765,564,000
+23.9%
57,517,977
-0.0%
14.37%
+4.1%
Q3 2015$617,743,000
+33.4%
57,517,9780.0%13.80%
-30.7%
Q2 2015$463,019,00057,517,97819.93%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$37,033,000100.00%
Artal Group S.A. 58,274,650$499,413,0006.25%
SECTOR GAMMA AS 854,592$7,324,0001.32%
NEA Management Company, LLC 2,382,286$20,416,0000.91%
Virtus ETF Advisers LLC 89,845$770,0000.67%
Malaga Cove Capital, LLC 59,701$512,0000.28%
MARSHALL WACE, LLP 736,545$6,312,0000.26%
USS Investment Management Ltd 2,741,942$22,607,0000.25%
CLEARBRIDGE, LLC 1,172,117$10,045,0000.22%
WEDBUSH SECURITIES INC 155,396$1,332,0000.17%
View complete list of LEXICON PHARMACEUTICALS INC shareholders